Loading Events
Featured Video Play Icon

Opportunities to prevent liver cancer via urgent acceleration of viral hepatitis elimination

13th November 2024 @ 12:00 pm - 1:00 pm GMT

Register
With almost a million new cases per year worldwide, liver cancer is the sixth most common cancer globally, with the highest rates of new cases and deaths seen in Asia and Africa. With the number of people diagnosed with or dying from liver cancer predicted to rise by 55% by 2040, liver cancer will place an increasingly heavy burden on health systems across the world.

The two major hepatitis viruses—hepatitis B virus and hepatitis C virus—are oncogenic, and viral hepatitis is a major cause of liver cancer. Despite the availability of an effective vaccine for hepatitis B and a cure for hepatitis C, efforts to test and treat individuals for viral hepatitis and to prevent these infections are suboptimal. Ramping up these efforts is a critical component of cancer prevention that must be integrated and implemented into cancer prevention efforts globally.

The session provides the audience with the opportunity to learn more about the link between viral hepatitis and liver cancer, and the key challenges facing efforts to eliminate viral hepatitis. The session will also focus on actionable aspects of hepatitis elimination with the end goal of preventing liver cancer.

Share This Event

  • This event has passed.

Details

  • Date: 13th November 2024
  • Time:
    12:00 pm - 1:00 pm GMT

Venue

  • Virtual